Alkermes plc. Revenue Breakdown
No Revenue Breakdown for ALKS on this site yet.
- 2025-12-31: Others Not split by product in the filing$1.48B100.00%; Total revenue $1.48B.
- 2024-12-31: Others Not split by product in the filing$1.56B100.00%; Total revenue $1.56B.
- 2023-12-31: Others Not split by product in the filing$1.66B100.00%; Total revenue $1.66B.
- 2022-12-31: Others Not split by product in the filing$1.11B100.00%; Total revenue $1.11B.
Source checked: the stored Revenue Breakdown page for ALKS.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $1.48B 100.00% | $1.48B |
| 2024-12-31 | Not split by product in the filing $1.56B 100.00% | $1.56B |
| 2023-12-31 | Not split by product in the filing $1.66B 100.00% | $1.66B |
| 2022-12-31 | Not split by product in the filing $1.11B 100.00% | $1.11B |
| 2021-12-31 | Not split by product in the filing $1.17B 100.00% | $1.17B |
| 2020-12-31 | Not split by product in the filing $1.04B 100.00% | $1.04B |
| 2019-12-31 | Not split by product in the filing $1.17B 100.00% | $1.17B |
| 2018-12-31 | Not split by product in the filing $1.09B 100.00% | $1.09B |
| 2017-12-31 | Not split by product in the filing $903.37M 100.00% | $903.37M |
| 2016-12-31 | Not split by product in the filing $745.69M 100.00% | $745.69M |
| 2015-12-31 | Not split by product in the filing $628.34M 100.00% | $628.34M |
| 2014-12-31 | Not split by product in the filing $618.79M 100.00% | $618.79M |
| 2013-12-31 | Not split by product in the filing $596.33M 100.00% | $596.33M |
| 2013-03-31 | Not split by product in the filing $575.55M 100.00% | $575.55M |
| 2012-03-31 | Not split by product in the filing $389.98M 100.00% | $389.98M |
| 2011-03-31 | Not split by product in the filing $186.64M 100.00% | $186.64M |
| 2010-03-31 | Not split by product in the filing $178.28M 100.00% | $178.28M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $496.01M 100.00% | $496.01M |
| 2026-03-31 | Not split by product $392.91M 100.00% | $392.91M |
| 2025-12-31 | Not split by product $384.55M 100.00% | $384.55M |
| 2025-09-30 | Not split by product $394.19M 100.00% | $394.19M |
| 2025-06-30 | Not split by product $390.66M 100.00% | $390.66M |
| 2025-03-31 | Not split by product $306.51M 100.00% | $306.51M |
| 2024-12-31 | Not split by product $429.99M 100.00% | $429.99M |
| 2024-09-30 | Not split by product $378.14M 100.00% | $378.14M |
| 2024-06-30 | Not split by product $399.13M 100.00% | $399.13M |
| 2024-03-31 | Not split by product $350.37M 100.00% | $350.37M |
| 2023-12-31 | Not split by product $377.48M 100.00% | $377.48M |
| 2023-09-30 | Not split by product $380.94M 100.00% | $380.94M |
| 2023-06-30 | Not split by product $617.40M 100.00% | $617.40M |
| 2023-03-31 | Not split by product $287.60M 100.00% | $287.60M |
| 2022-12-31 | Not split by product $304.67M 100.00% | $304.67M |
| 2022-09-30 | Not split by product $252.36M 100.00% | $252.36M |
| 2022-06-30 | Not split by product $276.22M 100.00% | $276.22M |
| 2022-03-31 | Not split by product $278.55M 100.00% | $278.55M |
| 2021-12-31 | Not split by product $324.46M 100.00% | $324.46M |
| 2021-09-30 | Not split by product $294.14M 100.00% | $294.14M |
| 2021-06-30 | Not split by product $303.72M 100.00% | $303.72M |
| 2021-03-31 | Not split by product $251.43M 100.00% | $251.43M |
| 2020-12-31 | Not split by product $280.00M 100.00% | $280.00M |
| 2020-09-30 | Not split by product $265.01M 100.00% | $265.01M |
| 2020-06-30 | Not split by product $247.53M 100.00% | $247.53M |
| 2020-03-31 | Not split by product $246.22M 100.00% | $246.22M |
| 2019-12-31 | Not split by product $412.73M 100.00% | $412.73M |
| 2019-09-30 | Not split by product $255.24M 100.00% | $255.24M |
| 2019-06-30 | Not split by product $279.87M 100.00% | $279.87M |
| 2019-03-31 | Not split by product $223.10M 100.00% | $223.10M |
| 2018-12-31 | Not split by product $315.76M 100.00% | $315.76M |
| 2018-09-30 | Not split by product $248.72M 100.00% | $248.72M |
| 2018-06-30 | Not split by product $304.64M 100.00% | $304.64M |
| 2018-03-31 | Not split by product $225.15M 100.00% | $225.15M |
| 2017-12-31 | Not split by product $275.37M 100.00% | $275.37M |
| 2017-09-30 | Not split by product $217.38M 100.00% | $217.38M |
| 2017-06-30 | Not split by product $218.84M 100.00% | $218.84M |
| 2017-03-31 | Not split by product $191.78M 100.00% | $191.78M |
| 2016-12-31 | Not split by product $213.51M 100.00% | $213.51M |
| 2016-09-30 | Not split by product $180.24M 100.00% | $180.24M |
| 2016-06-30 | Not split by product $195.16M 100.00% | $195.16M |
| 2016-03-31 | Not split by product $156.77M 100.00% | $156.77M |
| 2015-12-31 | Not split by product $163.10M 100.00% | $163.10M |
| 2015-09-30 | Not split by product $152.65M 100.00% | $152.65M |
| 2015-06-30 | Not split by product $151.37M 100.00% | $151.37M |
| 2015-03-31 | Not split by product $161.21M 100.00% | $161.21M |
| 2014-12-31 | Not split by product $175.16M 100.00% | $175.16M |
| 2014-09-30 | Not split by product $159.99M 100.00% | $159.99M |
| 2014-06-30 | Not split by product $153.42M 100.00% | $153.42M |
| 2014-03-31 | Not split by product $130.21M 100.00% | $130.21M |
| 2013-12-31 | Not split by product $154.48M 100.00% | $154.48M |
| 2013-09-30 | Not split by product $139.80M 100.00% | $139.80M |
| 2013-06-30 | Not split by product $138.63M 100.00% | $138.63M |
| 2013-03-31 | Not split by product $163.42M 100.00% | $163.42M |
| 2012-12-31 | Not split by product $135.91M 100.00% | $135.91M |
| 2012-09-30 | Not split by product $123.98M 100.00% | $123.98M |
| 2012-06-30 | Not split by product $152.24M 100.00% | $152.24M |
| 2012-03-31 | Not split by product $130.47M 100.00% | $130.47M |
| 2011-12-31 | Not split by product $125.64M 100.00% | $125.64M |
| 2011-09-30 | Not split by product $71.98M 100.00% | $71.98M |
| 2011-06-30 | Not split by product $61.88M 100.00% | $61.88M |
| 2011-03-31 | Not split by product $51.14M 100.00% | $51.14M |
| 2010-12-31 | Not split by product $43.98M 100.00% | $43.98M |
| 2010-09-30 | Not split by product $49.25M 100.00% | $49.25M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |